Scientific and regulatory leaders in the Asia-Pacific region met recently for an exchange of strategies to strengthen convergence and technical competence.
- March 2026 — CDMO Opportunities And Threats Report
- Target Selection Drives The Future Of CAR T Therapy In Solid Tumors
- Mastering Biotech's Insourcing/Outsourcing Trade-Offs
- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- Mitigating Challenges In Solid Tumor Delivery
- From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
- The Systems And Choreography Needed For Grade B ATMP Material Transfer
- Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Circular Single-Stranded Cell-Free DNA For Next-Gen Gene Editing
Next‑gen circular DNA payloads enhance gene insertion by improving stability, lowering cytotoxicity, and enabling precise, scalable integration across HDR, recombination, and transposition systems.
-
A Toolkit For Unraveling Protein Expression Patterns
Learn about a method that utilizes monoclonal antibodies and flow cytometry to analyze the metabolic state of individual immune cells, advancing immune research and immunotherapy.
-
Overcoming Rapid Growth Challenges With Process Liquid Preparation
With a helpful assessment and the right process liquid preparation services, the CDMO featured in this study was able to find a path toward meeting the surge in demand for a client's therapeutic .
-
Overcoming Bispecific Antibody Purification Challenges
Enhance the quality and safety of your BsAb therapeutics with a highly efficient with the right chromatography hydroxyapatite media.
-
Packing MabSelect™ And MabSelect SuRe™ Resins Using Verified Methods
Proper packing of MabSelect resins is crucial for efficient chromatography. Verified methods ensure stability, optimal flow, and reproducibility across scales using automated tools.
-
Automating High-Throughput Screens Using Patient-Derived Organoids
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
-
Ready To Demystify Organoids?
Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.
-
Rapid And Sensitive Detection Of Replication-Competent Lentivirus (RCL)
See how a rapid digital PCR workflow enables reliable detection of trace RCL levels while maintaining strong performance in complex samples, which support more confident decisions in manufacturing.
-
Contamination In The Shadows: Risks Lurking From Environmental Issues
Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.
-
Tackling CGT Challenges: Stirred-Tank Bioreactors For R&D And Commercial Manufacturing
Scalability remains a key bottleneck in CGT manufacturing. See how optimized stirred-tank bioreactor systems accelerate translation from clinical to commercial production.
NEWSLETTER ARCHIVE
- 04.15.26 -- Faster, More Efficient Cell & Gene Therapy Workflows with ddPCR
- 04.15.26 -- Mitigating Challenges In Solid Tumor Delivery
- 04.14.26 -- Innovation That's Redefining Aseptic Filling
- 04.14.26 -- The Systems And Choreography Needed For Grade B ATMP Material Transfer
- 04.14.26 -- STREAM Edition: Why Programmable Logic-Gated Cell Therapies Matter
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections